MedPath

TARO-IMIQUIMOD

TARO-IMIQUIMOD

Approved
DIN Number

02482975

Drug Class

Human

Market Date

N/A

Company
HC

Taro Pharmaceuticals Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02482975
AIG Number0135820001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D06BB10 IMIQUIMOD
Product Specifications
Dosage FormCream
Route of AdministrationTopical
AHFS Classification84:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

IMIQUIMODActive
Strength: 5 % / W/W
Monograph: IMIQUIMOD

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.